Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia.

Abstract:

:The purpose of this study was to determine the relative merits of idarubicin and daunorubicin in acute myeloid leukemia (AML) therapy. Thirty-two sites provided 214 previously untreated adults with AML aged 15 years or more who were randomized to receive for induction therapy cytarabine 100 mg/m2/d as a continuous 7-day infusion plus either daunorubicin 45 mg/m2/d (A + D) or idarubicin 13 mg/m2/d (A + I), daily on the first three days of treatment. Postremission therapy consisted of two courses of the induction regimen at the same daily doses, with the anthracycline administered for 2 days and cytarabine for 5. The complete response (CR) rates for evaluable patients were 70% (A + I) and 59% (A + D) (P = .08). The difference in CR rates was significant in patients aged 18 to 50 years (88% for A + I, 70% for A + D, P = .035). Resistant disease was a significantly more frequent cause of induction therapy failure with A + D than with A + I. Hyperleukocytosis (white blood cell count greater than 50,000/microL) unfavorably affected the attainment of CR with A + D but not with A + I. CR duration was significantly greater after A + I. CR duration was significantly greater after A + I treatment, and the survival of all randomized patients treated with A + I was significantly better than that observed after A + D treatment (median 12.9 months v 8.7 months, respectively, P = .038). Toxicity of the two treatments was similar, although A + I patients experienced more prolonged myelosuppression during consolidation therapy, and a greater incidence of mild chemical hepatitis was observed in the A + I group. It is concluded that, at the doses and schedule used in this study, A + I is superior to A + D for induction therapy of AML in adults.

journal_name

Blood

journal_title

Blood

authors

Wiernik PH,Banks PL,Case DC Jr,Arlin ZA,Periman PO,Todd MB,Ritch PS,Enck RE,Weitberg AB

subject

Has Abstract

pub_date

1992-01-15 00:00:00

pages

313-9

issue

2

eissn

0006-4971

issn

1528-0020

journal_volume

79

pub_type

临床试验,杂志文章,随机对照试验

相关文献

BLOOD文献大全
  • TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities.

    abstract::We examined TP53 mutation in 57 patients with myelodysplastic syndrome (MDS) at either the MDS phase or at the terminal leukemic phase using polymerase chain reaction-mediated single-strand conformation polymorphism (PCR-SSCP) analysis. TP53 mutations within exons 5 through 8 were found in seven patients. All these mu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kaneko H,Misawa S,Horiike S,Nakai H,Kashima K

    更新日期:1995-04-15 00:00:00

  • Response to hypoxia involves transforming growth factor-beta2 and Smad proteins in human endothelial cells.

    abstract::Oxygen deprivation (hypoxia) is a consistent component of ischemia that induces an inflammatory and prothrombotic response in the endothelium. In this report, it is demonstrated that exposure of endothelial cells to hypoxia (1% O(2)) increases messenger RNA and protein levels of transforming growth factor-beta2 (TGF-b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.12.3324

    authors: Akman HO,Zhang H,Siddiqui MA,Solomon W,Smith EL,Batuman OA

    更新日期:2001-12-01 00:00:00

  • Phosphorylation of protein 4.1 in Plasmodium falciparum-infected human red blood cells.

    abstract::The composition of the erythrocyte plasma membrane is extensively modified during the intracellular growth of the malaria parasite Plasmodium falciparum. It has been previously shown that an 80-kD phosphoprotein is associated with the plasma membrane of human red blood cells (RBCs) infected with trophozoite/schizont s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chishti AH,Maalouf GJ,Marfatia S,Palek J,Wang W,Fisher D,Liu SC

    更新日期:1994-06-01 00:00:00

  • Interleukin-9 regulates NF-kappaB activity through BCL3 gene induction.

    abstract::BCL3 encodes a protein with close homology to IkappaB proteins and interacts with p50 NF-kappaB homodimers. However, the regulation and transcriptional activity of BCL3 remain ill-defined. We observed here that interleukin-9 (IL-9) and IL-4, but not IL-2 or IL-3, transcriptionally upregulated BCL3 expression in T cell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Richard M,Louahed J,Demoulin JB,Renauld JC

    更新日期:1999-06-15 00:00:00

  • LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo.

    abstract::Low-density lipoprotein (LDL) receptor (LDLR) and LDLR-related protein (LRP) are members of the LDLR family of endocytic receptors. LRP recognizes a wide spectrum of structurally and functionally unrelated ligands, including coagulation factor VIII (FVIII). In contrast, the ligand specificity of LDLR is restricted to ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-11-4230

    authors: Bovenschen N,Mertens K,Hu L,Havekes LM,van Vlijmen BJ

    更新日期:2005-08-01 00:00:00

  • Characterization of the mouse von Willebrand factor promoter.

    abstract::Expression of the von Willebrand factor (vWF) gene is restricted to the endothelial and megakaryocyte lineages. Within the endothelium, expression of vWF varies between different vascular beds. We have previously shown that the human vWF promoter spanning a region between -2182 (relative to the start site of transcrip...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Guan J,Guillot PV,Aird WC

    更新日期:1999-11-15 00:00:00

  • Human regulatory T cells in allogeneic stem cell transplantation.

    abstract::GVHD is still one of the major complications after allogeneic stem cell transplantation. Whereas murine data have clearly shown the beneficial effects of regulatory T cells (Tregs) on the prevention of GVHD, data from the human system are rare. Here, we present a comparative dynamic analysis of CD4(+)CD25(hi)CD127(lo/...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-05-352708

    authors: Ukena SN,Velaga S,Geffers R,Grosse J,Baron U,Buchholz S,Stadler M,Bruder D,Ganser A,Franzke A

    更新日期:2011-09-29 00:00:00

  • Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase.

    abstract::Reduced oxygenation of a variety of cells results in transcriptional upregulation of several genes, including the hematopoietic hormone erythropoietin, the angiogenic vascular endothelial growth factor (VEGF), and glycolytic enzymes such as aldolase. Recently, the heme protein cytochrome b558 of the nicotinamide adeni...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wenger RH,Marti HH,Schuerer-Maly CC,Kvietikova I,Bauer C,Gassmann M,Maly FE

    更新日期:1996-01-15 00:00:00

  • Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo.

    abstract::Mig, the monokine induced by interferon-gamma, is a CXC chemokine active as a chemoattractant for activated T cells. Mig is related functionally to interferon-inducible protein 10 (IP-10), with which it shares a receptor, CXCR3. Previously, IP-10 was found to have antitumor activity in vivo. In the present study, muri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sgadari C,Farber JM,Angiolillo AL,Liao F,Teruya-Feldstein J,Burd PR,Yao L,Gupta G,Kanegane C,Tosato G

    更新日期:1997-04-15 00:00:00

  • Distinct functional programming of human fetal and adult monocytes.

    abstract::Preterm birth affects 1 out of 9 infants in the United States and is the leading cause of long-term neurologic handicap and infant mortality, accounting for 35% of all infant deaths in 2008. Although cytokines including interferon-γ (IFN-γ), interleukin-10 (IL-10), IL-6, and IL-1 are produced in response to in utero i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-11-536094

    authors: Krow-Lucal ER,Kim CC,Burt TD,McCune JM

    更新日期:2014-03-20 00:00:00

  • Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease.

    abstract::The intestinal microbiota in allogeneic bone marrow transplant (allo-BMT) recipients modulates graft-versus-host disease (GVHD), a systemic inflammatory state initiated by donor T cells that leads to colitis, a key determinant of GVHD severity. Indole or indole derivatives produced by tryptophan metabolism in the inte...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-03-838193

    authors: Swimm A,Giver CR,DeFilipp Z,Rangaraju S,Sharma A,Ulezko Antonova A,Sonowal R,Capaldo C,Powell D,Qayed M,Kalman D,Waller EK

    更新日期:2018-12-06 00:00:00

  • Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models.

    abstract::ADAMTS13 metalloprotease cleaves von Willebrand factor (VWF), thereby inhibiting platelet aggregation and arterial thrombosis. An inability to cleave ultralarge VWF resulting from hereditary or acquired deficiency of plasma ADAMTS13 activity leads to a potentially fatal syndrome, thrombotic thrombocytopenic purpura (T...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-587139

    authors: Pickens B,Mao Y,Li D,Siegel DL,Poncz M,Cines DB,Zheng XL

    更新日期:2015-05-21 00:00:00

  • Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia.

    abstract::Mutations in the kinase domain (KD) of BCR-ABL are the most prevalent mechanism of acquired imatinib resistance in patients with chronic myeloid leukemia (CML). Here we examine predisposing factors underlying acquisition of KD mutations, evidence for acquisition of mutations before and during therapy, and whether the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-066936

    authors: O'Hare T,Eide CA,Deininger MW

    更新日期:2007-10-01 00:00:00

  • A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.

    abstract::We report two patients with a distinctive biphenotypic hematologic disorder characterized by lymphoblastic lymphoma (LBL), eosinophilia, and myeloid malignancy and/or hyperplasia associated with a t(8;13)(p11;q11) chromosomal translocation in both bone marrow and lymph node specimens. Both patients presented with lymp...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Inhorn RC,Aster JC,Roach SA,Slapak CA,Soiffer R,Tantravahi R,Stone RM

    更新日期:1995-04-01 00:00:00

  • BVL-1-like VL30 promoter sustains long-term expression in erythroid progenitor cells.

    abstract::Congenital blood disorders are common and yet clinically challenging globin disorders. Gene therapy continues to serve as a potential therapeutic method to treat these disorders. While tremendous advances have been made in vivo, gene delivery protocols and vector prototypes still require optimization. Alternative cis-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-07-2105

    authors: Staplin WR,Knezetic JA

    更新日期:2003-03-01 00:00:00

  • Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis.

    abstract::In the present study, we investigated disease characteristics and clinical outcome in young patients (< 40 years) with World Health Organization (WHO)-defined essential thrombocythemia (ET) compared with early/prefibrotic primary myelofibrosis (PMF) with presenting thrombocythemia. We recruited 213 young patients (med...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-407981

    authors: Barbui T,Thiele J,Carobbio A,Passamonti F,Rumi E,Randi ML,Bertozzi I,Vannucchi AM,Gisslinger H,Gisslinger B,Finazzi G,Ruggeri M,Rodeghiero F,Rambaldi A,Gangat N,Tefferi A

    更新日期:2012-07-19 00:00:00

  • The von Willebrand factor D'D3 assembly and structural principles for factor VIII binding and concatemer biogenesis.

    abstract::D assemblies make up half of the von Willebrand factor (VWF), yet are of unknown structure. D1 and D2 in the prodomain and D'D3 in mature VWF at Golgi pH form helical VWF tubules in Weibel Palade bodies and template dimerization of D3 through disulfides to form ultralong VWF concatemers. D'D3 forms the binding site fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-10-876300

    authors: Dong X,Leksa NC,Chhabra ES,Arndt JW,Lu Q,Knockenhauer KE,Peters RT,Springer TA

    更新日期:2019-04-04 00:00:00

  • Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia.

    abstract::The principal aim of our study was to investigate whether patients transplanted more than 20 years ago for β-thalassemia major had a different health-related quality of life (HRQoL) compared with the general population. The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) and the Functional Assessment o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-05-502658

    authors: La Nasa G,Caocci G,Efficace F,Dessì C,Vacca A,Piras E,Sanna M,Marcias M,Littera R,Carcassi C,Lucarelli G

    更新日期:2013-09-26 00:00:00

  • MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis.

    abstract::MicroRNAs (miRNAs) have emerged as important regulators of the immune system. However, despite this prominence, our understanding of the function of miRNAs in the early hematopoietic stages is incomplete. In this study, we found that miR-139-5p negatively regulated the proliferation of hematopoietic stem cells and pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-02-702464

    authors: Choi J,Kim YK,Park K,Nah J,Yoon SS,Kim DW,Kim VN,Seong RH

    更新日期:2016-10-27 00:00:00

  • Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance.

    abstract::Murine autoreactive anti-Smith (Sm) B cells are negatively regulated by anergy and developmental arrest, but are also positively selected into the marginal zone (MZ) and B-1 B-cell populations. Despite positive selection, anti-Sm production occurs only in autoimmune-prone mice. To investigate autoreactive B-cell activ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-12-006858

    authors: Qian Y,Conway KL,Lu X,Seitz HM,Matsushima GK,Clarke SH

    更新日期:2006-08-01 00:00:00

  • Chemotactic factor enhancement of superoxide release from fluoride and phorbol myristate acetate stimulated neutrophils.

    abstract::Human neutrophils exposed to chemotactic concentrations of zymosan-activated serum (ZAS) and a formylated chemotactic peptide (FMLP, 10(-7)--10(-9) M) were markedly enhanced in their ability to generate superoxide (O2-) upon stimulation with either sodium fluoride or phorbol myristate acetate (PMA). For both fluoride ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: English D,Roloff JS,Lukens JN

    更新日期:1981-07-01 00:00:00

  • Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression.

    abstract::We previously reported that RO(+) expression correlated with increased mutation, activation, and selection among human germinal center (GC) B cells. Here, we subdivided human tonsillar B cells, including IgD(-)CD38(+) GC B cells, into different fractions based on RB expression. Although each subset contained RB(+) cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-03-145979

    authors: Jackson SM,Harp N,Patel D,Wulf J,Spaeth ED,Dike UK,James JA,Capra JD

    更新日期:2009-04-23 00:00:00

  • Farnesyltransferase inhibitor R115777 in myelodysplastic syndrome: clinical and biologic activities in the phase 1 setting.

    abstract::R115777 is a potent farnesyltransferase (FTase) inhibitor with substantial antitumor activity in preclinical models. We conducted a phase 1 study (3 + 3 design) of R115777 in patients with myelodysplastic syndrome (MDS). R115777 was administered twice daily (3-weeks-on/1-week-off schedule for 8 weeks) (starting dosage...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2002-11-3359

    authors: Kurzrock R,Kantarjian HM,Cortes JE,Singhania N,Thomas DA,Wilson EF,Wright JJ,Freireich EJ,Talpaz M,Sebti SM

    更新日期:2003-12-15 00:00:00

  • Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.

    abstract::Studies have demonstrated that common polymorphisms in Th1 and Th2 cytokine genes can alter gene expression, modulate the balance between Th1/Th2 responsiveness, and influence susceptibility for autoimmune disorders, infectious diseases, and cancer. We analyzed one or more single nucleotide polymorphisms (SNPs) in 20 ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4160

    authors: Lan Q,Zheng T,Rothman N,Zhang Y,Wang SS,Shen M,Berndt SI,Zahm SH,Holford TR,Leaderer B,Yeager M,Welch R,Boyle P,Zhang B,Zou K,Zhu Y,Chanock S

    更新日期:2006-05-15 00:00:00

  • c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemia.

    abstract::Low-dose interferon-alpha (IFN-alpha) therapy is consistently effective in the treatment of hairy cell leukemia (HCL). In two cases of resistance to IFN-alpha administration, we diagnosed variant HCL, a form of HCL with intermediate features between typical HCL and B cell prolymphocytic leukemia. We tried to distingui...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lehn P,Sigaux F,Grausz D,Loiseau P,Castaigne S,Degos L,Flandrin G,Dautry F

    更新日期:1986-10-01 00:00:00

  • Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses.

    abstract::Factor V Leiden (FVL) is associated with venous thrombosis; however, an association between FVL and arterial thrombosis remains controversial. We investigated FVL as a risk factor for myocardial infarction (MI), ischemic stroke (IS), or non-MI ischemic heart disease (non-MI-IHD). The design was 3 case-control studies ...

    journal_title:Blood

    pub_type: 杂志文章,meta分析

    doi:10.1182/blood-2002-01-0111

    authors: Juul K,Tybjaerg-Hansen A,Steffensen R,Kofoed S,Jensen G,Nordestgaard BG

    更新日期:2002-07-01 00:00:00

  • Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features.

    abstract::The peripheral blood lymphocyte surface markers and clinical features of 38 patients with common variable immunodeficiency (CVID) were assessed. These studies identified a subset of CVID consisting of 14 of the 38 patients with a distinctive T-cell immunophenotype and clinical findings. The phenotypic changes were cha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wright JJ,Wagner DK,Blaese RM,Hagengruber C,Waldmann TA,Fleisher TA

    更新日期:1990-11-15 00:00:00

  • Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH).

    abstract::Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic anemia in which venous thrombosis is the most common cause of death. Here we address the risk factors for thrombosis and the role of warfarin prophylaxis in PNH. The median follow-up of 163 PNH patients was 6 years (range, 0.2-38 years). Of the patient...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0009

    authors: Hall C,Richards S,Hillmen P

    更新日期:2003-11-15 00:00:00

  • Fetal erythropoiesis in juvenile chronic myelocytic leukemia.

    abstract::Red cell enzymes, 2,3-diphosphoglycerate (2,3-DPG) and adenosine triphosphate (ATP), were evaluated in a 23-mo-old boy with juvenile chronic myelocytic leukemia (JCML) at the onset of his illness and 6 mo later during the accelerated phase. The activities of the age-dependent red cell enzymes, hexokinase, aldolase, py...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Travis SF

    更新日期:1983-09-01 00:00:00

  • Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses.

    abstract::Little is known about the ontogeny of naturally occurring CD4(+)CD25(+) regulatory/suppressor T cells that play a major role in maintaining self-tolerance in mice and humans. In rodents, thymectomy on day 3 of life leads to multiple organ-specific autoimmune diseases that can be prevented by adoptive transfer of regul...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-4051

    authors: Darrasse-Jèze G,Marodon G,Salomon BL,Catala M,Klatzmann D

    更新日期:2005-06-15 00:00:00